SalvaRx Group PLC logo

SalvaRx Group PLC

Europe, Cambridgeshire, United Kingdom, Ramsey

Description

SalvaRx Group PLC is a drug discovery and development company focused on immune-oncology & invests in novel cancer immune-therapies.

Investor Profile

SalvaRx Group PLC has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Therapeutics.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SalvaRx Group PLC frequently co-invest with?

Batterson Venture Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
VCapital
North America, Illinois, United States, Chicago
Co-Investments: 1

Which angels does SalvaRx Group PLC often collaborate with?

JM
Europe, Isle of Man
Shared Deals: 1
DD
Europe, NA - Isle of Man, Isle of Man, Douglas
Shared Deals: 1

What are some of recent deals done by SalvaRx Group PLC?

Intensity Therapeutics

Norwalk, Connecticut, United States

Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.

BiopharmaBiotechnologyTherapeutics
Series AJun 28, 2016
Amount Raised: $10,000,000